Washington, D.C. – The Board of Pharmacy Specialties (BPS) is excited to announce that solid organ transplantation pharmacy is formally recognized as the thirteenth pharmacy specialty.


Andrea A. Iannucci, PharmD, BCOP, the 2018 Chair of the BPS Board of Directors, Assistant Chief Pharmacist, Oncology and Investigational Drugs Services at the University of California – Davis Medical Center (UCDMC), and Clinical Professor with the UCSF School of Pharmacy and UCDMC School of Medicine provided the following comments: “BPS is very pleased to formally acknowledge solid organ transplantation as a new pharmacy specialty. Given that a new patient is added to the national transplant waiting list every 10 minutes and that these patients receive as many as 8-15 medications, many of which are expensive or have a narrow therapeutic index, the need for pharmacist specialists to ensure the best patient outcomes is evident.”


Solid Organ Transplantation Pharmacy

The petition to recognize this pharmacy specialty was submitted jointly by the American College of Clinical Pharmacy and the American Society of Health-System Pharmacists. In their petition, solid organ transplantation pharmacy practice is defined as:


Solid organ transplantation (SOT) pharmacist specialists have the specialized training and knowledge needed to manage complex medication regimens unique to the SOT population. Additionally, they are experts in meeting clinical and regulatory needs not encountered in any other pharmacy specialty. They care for patients throughout all phases of SOT, of all ages, and in various health care settings. SOT pharmacist specialists provide evidence-based, patient-centered medication management. They design, implement, monitor, and modify pharmacotherapeutic plans to improve safety and efficacy, which leads to optimal short-term and long-term patient and allograft outcomes. Core responsibilities of SOT pharmacist specialists are to analyze and reevaluate multifaceted clinical and outcomes data to improve care and demonstrate ongoing quality assessment and process improvement as required by regulatory agencies. Finally, SOT pharmacist specialists are integral members of the interprofessional transplantation team that facilitate medication adherence and pharmacotherapy education.


Next Steps

  • BPS will issue a call for nominations for Solid Organ Transplantation Pharmacy Specialty Council appointments in early October. The deadline for nominations will be November 16, 2018.
  • BPS will appoint nine members to the Specialty Council by December 31, 2018.
  • The Council will convene, on dates to be determined, in February 2019.
  • Examination item writing for the new specialty will commence in the first quarter, 2019, with the first examination planned for September 2020.


About the Board of Pharmacy Specialties

The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of BPS is to improve patient care by positioning BPS Board-Certified Pharmacist Specialists as integral members of multidisciplinary healthcare teams, through recognition and promotion of specialized training, knowledge, and skills for pharmacists in the United States and internationally. Board certification is a recognized credential for determining which pharmacists are qualified to contribute at advanced practice levels given the rigorous standards mandated by BPS board certification and recertification. BPS currently recognizes more than 38,000 active pharmacist certifications in nine specialties.


BPS Contact

Alexander Jean-Baptiste

Social Media & Content Marketing Manager


(202) 760-3836